Glial responses, clusterin, and complement in permanent focal cerebral ischemia in the mouse

GLIA

Volumn 31, Issue 1, 2000, Pages 39-50

  Van Beek, Johan ^a,b   Chan, Philippe ^a   Bernaudin, Myriam ^b   Petit, Edwige ^b   Mackenzie, Eric T ^b   Fontaine, Marc ^a  

^a INSERM   (France)

^b UNIVERSITÉ DE CAEN   (France)

Author keywords

Astrocytes; Complement; Focal ischemia; Inflammation; Macrophages; Mice; Microglia

Indexed keywords

ANIMAL MODEL; BRAIN CORTEX; BRAIN ISCHEMIA; CELL ACTIVATION; CLUSTERIN; COMPLEMENT FACTOR; GLIA; GLIAL FIBRILLARY ACIDIC PROTEIN; IN SITU HYBRIDIZATION; MESSENGER RNA; MIDDLE CEREBRAL ARTERY; MOUSE; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ASTROCYTES; BRAIN ISCHEMIA; CLUSTERIN; COMPLEMENT C1Q; COMPLEMENT C4; COMPLEMENT SYSTEM PROTEINS; GLIAL FIBRILLARY ACIDIC PROTEIN; GLYCOPROTEINS; MALE; MICE; MOLECULAR CHAPERONES; NEUROGLIA;

EID: 0034046960     PISSN: 08941491     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-1136(200007)31:1<39::AID-GLIA40>3.0.CO;2-1     Document Type: Article

References (52)

1. Andrews BS, Shadforth M, Cunningham P, Davis JS. 1981. Demonstration of a C1q receptor on the surface of human endothelial cells. J Immunol 127:1075-1080.
2. Bellander B-M, von Holst H, Fredman P, Svensson M. 1996. Activation of the complement cascade and increase of clusterin in the brain following a cortical contusion in the adult rat. J Neurosurg 85:468-475.
3. Bernaudin M, Nouvelot A, MacKenzie ET, Petit E. 1997. Selective neuronal vulnerability and specific glial reactions in hippocampal and neocortical organotypic cultures submitted to ischemia. Exp Neurol 150:30-39.
4. Bodjarian N, Jamali S, Boisset N, Tadié M. 1997. Strong expression of GFAP mRNA in rat hippocampus after a closed head injury. Neuroreport 8:3951-3956.
5. Clark RK, Lee EV, Fish CJ, White RF, Price WJ, Jonak ZL, Feuerstein G, Barone FC. 1993. Development of tissue damage, inflammation and resolution following stroke: an immunohistochemical and quantitative planimetric study. Brain Res Bull 31:565-572.
6. Clark RK, Lee EV, White RF, Jonak ZL, Feuerstein GZ, Barone FC. 1994. Reperfusion following focal stroke hastens inflammation and resolution of ischemic injured tissue. Brain Res Bull 35:387-392.
7. Colton CA, Abel C, Patchett J, Keri J, Yao J. 1992. Lectin staining of cultured CNS microglia. J Histochem Cytochem 40:505-512.
8. Daha MR, Miltenburg AM, Hiemstra PS, Klar-Mohamad N, Van Es LA, Van Hinsberg VW. 1988. The complement subcomponent C1q mediates binding of immune complexes and aggregates to endothelial cells in vitro. Eur J Immunol 18:783-787.
9. Danik M, Chabot J-G, Hassan-Gonzalez D, Suh M, Quirion R. 1993. Localization of sulfated glycoprotein-2/clusterin mRNA in the rat brain by in situ hybridization. J Comp Neurol 334:209-227.
10. Davies CA, Loddick SA, Stroemer RP, Hunt J, Rothwell NJ. 1998. An integrated analysis of the progression of cell responses induced by permanent focal middle cerebral artery occlusion in the rat. Exp Neurol 154:199-212.
11. Dietzschold B, Schwaeble W, Schäfer MKH, Hooper DC, Zehng YM, Petry F, Sheng H, Fink T, Loos M, Koprowski H, Weihe E. 1995. Expression of C1q, a subcomponent of the rat complement system, is dramatically enhanced in brains of rats with either Borna disease or experimental allergic encephalomyelitis. J Neurol Sci 130:11-16.
12. Eikelenboom P, Veerhuis R. 1996. The role of complement and activated microglia in the pathogenesis of Alzheimer's disease. Immunopharmacology 17:673-680.
13. Gasque P, Julen N, Ischenko AM, Picot C, Mauger C, Chauzy C, Ripoche J, Fontaine M. 1992. Expression of complement components of the alternative pathway by glioma cell lines. J Immunol 149:1381-1387.
14. Gasque P, Ischenko AM, Legoedec J, Mauger C, Schouft M-T, Fontaine M. 1993. Expression of the complement classical pathway by human glioma in culture. J Biol Chem 268:25068-25074.
15. Gasque P, Fontaine M, Morgan BP. 1995a. Complement expression in human brain. Biosynthesis of terminal pathway components and regulators in human glial cells and cell lines. J Immunol 154:4726-4733.
16. Gasque P, Chan P, Fontaine M, Ischenko A, Lamacz M, Götze O, Morgan BP. 1995b. Identification and charaterization of the complement C5a anaphylatoxin receptor on human astrocytes. Relevance to inflammation in the brain. J Immunol 155:4882-4889.
17. Gasque P, Thomas A, Fontaine M, Morgan BP. 1996. Complement activation on human neuroblastoma cell lines in vitro: route of activation and expression of functional complement regulatory proteins. J Neuroimmunol 66:29-40.
18. Gasque P, Singhrao SK, Neal JW, Götze O, Morgan BP. 1997. Expression of the receptor for complement C5a (CD88) is up-regulated on reactive astrocytes, microglia, and endothelial cells in the inflamed human central nervous system. Am J Pathol 150:31-41.
19. Gasque P, Singhrao SK, Neal JW, Wang P, Sayah S, Fontaine M, Morgan BP. 1998. The receptor for complement anaphylatoxin C3a is expressed by myeloid cells and non myeloid cells in inflamed human central nervous system: analysis in multiple sclerosis and bacterial meningitis. J Immunol 160:3543-3554.
20. Gehrmann J, Bonnekoh P, Miyazawa T, Hossmann K-A, Kreutzberg GW. 1992. Immunocytochemical study of an early microglial activation in ischemia. J Cereb Blood Flow Metab 12:257-269.
21. Giulian D, Vaca K. 1993. Inflammatory glia mediate delayed neuronal damage after ischemia in the central nervous system. Stroke 24: 84-90.
22. Gotti B, Benavides J, MacKenzie ET, Scatton B. 1990. The pharmacotherapy of focal cortical ischaemia in the mouse. Brain Res 522: 290-307.
23. Guo WX, Ghebrehiwet B, Weksler B, Schweitzer K, Peerschke EI. 1999. Up-regulation of endothelial cell binding proteins/receptors for complement component C1q by inflammatory cytokines. J Lab Clin Med 133:541-550.
24. Haga S, Aizawa T, Ishii T, Ikeda K. 1996. Complement gene expression in mouse microglia and astrocytes in culture: comparison with mouse peritoneal macrophages. Neurosci Lett 216:191-194.
25. Huang J, Kim LJ , Mealey R, Marsh HC, Zhang Y, Tenner AJ, Connolly ES, Pinsky DJ. 1999. Neuronal protection in stroke by an sLex-glycosylated complement inhibitory protein. Science 285:595-599.
26. Ischenko A, Sayah S, Patte C, Andreev S, Gasque P, Schouft M-T, Vaudry H, Fontaine M. 1998. Expression of a functional anaphylatoxin C3a receptor by astrocytes. J Neurochem 71:2487-2496.
27. Johnson SA, Lampert-Etchells M, Pasinetti GM, Rozovski I, Finch CE. 1992. Complement mRNA in the mammalian brain: responses to Alzheimer's disease and experimental brain lesioning. Neurobiol Aging 13:641-648.
28. Johnson SA, Young-Chan CS, Laping NJ, Finch CE. 1996. Perforant path transection induces complement C9 deposition in hippocampus. Exp Neurol 138:198-205.
29. Lampert-Etchells M, McNeill TH, Laping NJ, Zarow C, Finch CE, May PC. 1991. Sulfated glycoprotein-2 is increased in rat hippocampus following entorhinal cortex lesioning. Brain Res 563:101-106.
30. Lampert-Etchells M, Pasinetti GM, Finch CE, Johnson SA. 1993. Regional localization of cells containing complement C1q and C4 mRNAs in the frontal cortex during Alzheimer's disease. Neurodegeneration 2:111-121.
31. Levi-Strauss M, Mallat M. 1987. Primary cultures of murine astrocytes produce C3 and factor B, two components of the alternative pathway of complement activation. J Immunol 139:2361-2366.
32. May PC, Robison P, Fuson K, Smalstig B, Stephenson D, Clemens JA. 1992. Sulfated glycoprotein-2 expression increases in rodent brain after transient global ischemia. Mol Brain Res 15:33-39.
33. May PC, Clemens JA, Panetta JA, Smalstig EB, Stephenson D, Fuson KS. 1996. Induction of sulfated glycoprotein-2 (clusterin) and glial fibrillary acidic protein (GFAP) RNA expression following transient global ischemia is differentially attenuated by LY231617. Mol Brain Res 42:145-148.
34. Morgan BP. 1990. Complement: clinical aspects and relevance to disease. London: Academic Press.
35. Pasinetti GM, Finch CE. 1991. Sulfated glycoprotein-2 (SGP-2) mRNA is expressed in rat striatal astrocytes following ibotenic acid lesions. Neurosci Lett 130:1-4.
36. Pasinetti GM, Johnson SA, Rozovsky I, Lampert-Etchells M, Morgan DG, Gordon MN, Morgan TE, Willoughby D, Finch CE. 1992. Complement C1qB and C4 mRNAs responses to lesioning in rat brain. Exp Neurol 118:117-125.
37. Ripoche J, Mitchell JA, Erdei A, Madin C, Moffatt B, Mokoena T, Gordon S, Sim RB. 1988. Interferon gamma induces synthesis of complement alternative pathway proteins by human endothelial cells in culture. J Exp Med 168:1917-1922.
38. Rupalla K, Allegrini PR, Sauer D, Wiessner C. 1998. Time course of migroglia activation and apoptosis in various brain regions after permanent focal cerebral ischemia in mice. Acta Neuropathol (Berl) 96:172-178.
39. Sayah S, Patte C, Gasque P, Chan P, Ischenko A, Vaudry H, Fontaine M. 1997. Characterization of rat C5a anaphylatoxin receptor (C5aR): cloning of rat C5aR cDNA and study of C5aR expression by rat astrocytes. Mol Brain Res 48:215-222.
40. Shen Y, Halperin JA, Lee CM. 1995. Complement-mediated neurotoxicity is regulated by homologous restriction . Brain Res 671:282-292.
41. Shen Y, Li R, McGeer EG, McGeer PL. 1997. Neuronal expression of mRNAs for complement proteins of the classical pathway in Alzheimer brain. Brain Res 769: 391-395.
42. Stahel PF, Kossmann T, Morganti-Kossmann MC, Hans VHJ, Barnum SR. 1997a. Experimental diffuse axonal injury induces enhanced neuronal C5a receptor mRNA expression in rats. Mol Brain Res 150:205-212.
43. Stahel PF, Frei K, Eugster HP, Fontana A, Hummel KM, Wetsel RA, Ames RS, Barnum SR. 1997b. TNF-α-mediated expression of the receptor for anaphylatoxin C5a on neurons in experimental Listeria meningoencephalitis. J Immunol 159:861-869.
44. Stahel PF, Morganti-Kossman MC, Kossman T. 1998. The role of complement system in traumatic brain injury. Brain Res Rev 27: 243-246.
45. Steward O, Kelly MS, Torre ER. 1993. The process of reinnervation in the dentate gyms of adult rats: temporal relationship between the changes in the levels of glial fibrillary acidic protein (GFAP) and GFAP mRNA in reactive astrocytes. Exp Neurol 124:167-183.
46. Terai K, Walker DG, McGeer EG, McGeer PL. 1997. Neurons express proteins of the classical complement pathway in Alzheimer disease. Brain Res. 769:385-390.
47. Van Beek J, Bernaudin M, Petit E, Gasque P, Nouvelot A, MacKenzie ET, Fontaine M. 1999. Expression of receptors for complement anaphylatoxins C3a and C5a following permanent focal cerebral ischemia in the mouse. Exp Neurol. 161:373-382.
48. Vasthare US, Barone FC, Sarau HM, Rossenwasser RH, DiMartino M, Young WF, Tuma RF. 1998. Complement depletion improves neurological function in cerebral ischemia. Brain Res Bull 45:413-419.
49. Vivien D, Bernaudin M, Buisson A, Divoux D, MacKenzie ET, Nouvelot A. 1998. Evidence of type I and type II transforming growth factor-β receptors in central nervous tissues: changes induced by focal cerebral ischemia. J Neurochem 70:2296-2304.
50. Walker DG, Kim SU, McGeer PL. 1998. Expression of complement C4 and C9 by human astrocytes. Brain Res 809:31-38.
51. Webster SD, Park M, Fonseca MI, Tenner AJ. 2000. Structural and functional evidence for microglial expression of C1qR(P), the C1q receptor that enhances phagocytosis. J Leukoc Biol 67:109-116.
52. Yamashita K, Vogel P, Fritze K, Back T, Hossmann K-A, Wiessner C. 1996. Monitoring the temporal and spatial activation pattern of astrocytes in focal cerebral ischemia using in situ hybridization to GFAP mRNA: comparison with sgp-2 and hsp70 mRNA and the effect of glutamate receptor antagonists. Brain Res 735:285-297.